Bristol-Myers Squibb Company 13D and 13G filings for Prime Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-04 4:20 pm Purchase |
2023-09-30 | 13G | Prime Medicine, Inc. PRME |
BRISTOL MYERS SQUIBB CO BMY |
11,006,163 8.400% |
11,006,163 (New Position) |
Filing |